Therapeutic angiogenesis: Theoretic problems using vascular endothelial growth factor

Current Cardiology Reports

Volumn 2, Issue 1, 2000, Pages 24-28

  Baumgartner, Iris ^a  

^a Kantonsspital Frauenfeld   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR; ISOPROTEIN; LYMPHOKINE; VASCULOTROPIN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL; CELL DIVISION; COLLATERAL CIRCULATION; CYTOLOGY; GENE THERAPY; GENETICS; HUMAN; ISCHEMIA; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSIOLOGY; REVIEW; VASCULAR ENDOTHELIUM;

ANGIOPLASTY, BALLOON; ANIMALS; CELL DIVISION; COLLATERAL CIRCULATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE THERAPY; HUMANS; ISCHEMIA; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033649043     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-000-0021-6     Document Type: Article

References (14)

1. Folkman J: Clinical applications of research on angiogenesis. N Engl J Med 1995, 333:1757-1763.
2. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996, 86:353-364.
3. Baumgartner I, Pieczek A, Manor O, et al. : Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998, 97:114-1123.
4. Barger AC, Beeuwkes R, Lainey L, Silverman KJ: Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984, 310:175-177.
5. Moulton KS, Heller E, Konerding MA, et al. : Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolip oprotein E-deficient mice. Circulation 1999, 99:1726-1732.
6. Isner JM: Cancer and atherosclerosis. Circulation 1999, 99:1653 1655.
7. Inoue M, Itoh H, Ueda M, et al. : Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998, 98:2108-2116
8. Arras M, Ito WD, Scholz D, et al. : Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb. J Clin Invest 1997, 101:40 50.
9. Schaper W, Piek JJ, Munoz-Chapuli R, et al. : Collateral circulation of the heart. In Angiogenesis and cardiovascular disease. Edited by Ware JA, Simons M. New York: Oxford University Press; 1999:159-198.
10. Longlend CJ: The collateral circulation of the limb. Ann R Coll Sur Engl 1953, 13:161-166.
11. Schaper J, Weibrauch D: Collateral vessel development in the porcine and canine heart. In Collateral circulation: heart, brain, kidney, limbs. Edited by Schaper W, Schaper J. Boston: Kluwer; 1993:65 102.
12. Sellke FW, Quille JE, Brooks LA, Harrison DG: Endothelial modulation of the coronary vasculature in vessels perfused via mature collaterals. Circulation 1990, 81:1938 1947.
13. Takeshita S, Isshiki T, Tanaka E: Use of synchrotron radiation microangiography to assess development of small collateral arteries in a rat model of hindlimb ischemia. Circulation 1997, 95 805-808.
14. Laham R, Tofukuji M, Sellke F, Simons M: Vascular endothelial growth facto (VEGF) affects microvessels but not epicardial coronary arteries and veins. Circulation 1997, 96:I551.